Rural South African Hospital Study Finds Most Prostate Cancer Cases Arrive at Advanced Stage

…

…

The finding that more than six in ten men at Nelson Mandela Academic Hospital already had high-risk disease when first assessed places this rural Eastern Cape cohort among the later-presenting prostate cancer populations described in the international literature. In high-income settings, widespread prostate-specific antigen (PSA) testing has shifted the stage distribution at diagnosis dramatically, with a large share of tumours now detected while still localised. In much of sub-Saharan Africa, by contrast, organised screening programmes are rare, PSA testing is often available only in larger facilities, and many men first encounter the health system only after symptoms such as urinary obstruction, haematuria, or bone pain have developed. Because prostate cancer frequently grows silently for years before producing symptoms, symptom-driven presentation almost guarantees that a substantial fraction of cases will already have spread beyond the gland, which is consistent with the 61.2% high-risk proportion observed here.

The age profile of the cohort deserves particular attention. With a mean age of 72.6 years and a standard deviation of 8.8 years, these men were diagnosed well beyond the age at which most curative-intent treatment decisions are made in wealthier health systems. The steep gradient in risk category by age, with 87.8% of men aged 80 and older classified as high-risk, reflects both the natural history of the disease, which becomes more aggressive and more likely to have disseminated with advancing age, and the cumulative effect of diagnostic delay over many years. This has practical consequences: older men with high-risk disease are less likely to tolerate or benefit from radical local treatment, and their care tends to shift toward androgen-deprivation therapy and palliation. In a resource-constrained rural setting, this means the health system absorbs patients whose disease might have been managed far more effectively, and at lower cost, had it been detected a decade earlier.

The geographic analysis adds an important nuance. Although the overwhelming majority of patients came from OR Tambo District, and specifically from the King Sabata Dalindyebo sub-district that hosts Mthatha, the absence of a statistically significant association between district of residence and risk category (p = 0.932) suggests that late presentation is not simply a function of distance from the referral hospital. Patients travelling from Amathole, Chris Hani, Alfred Nzo, and Joe Gqabi districts arrived with broadly similar risk profiles to those living close to the quaternary centre. This pattern implies that the drivers of late diagnosis operate upstream of geography: they include low community awareness of prostate cancer, limited PSA testing at primary care level, inconsistent clinical examination of older men, and referral cultures in which urological symptoms in elderly men may be managed conservatively rather than investigated. If distance alone were the dominant barrier, one would expect nearby patients to present earlier; the data do not support that expectation.

At the same time, the concentration of patients in the hospital’s home district should not be dismissed. Proximity to Nelson Mandela Academic Hospital plausibly influences both who is referred and who survives long enough to be counted in hospital records. Men from more distant districts may die in their communities without ever reaching the quaternary centre, or may be managed entirely at regional hospitals, meaning the 224 analysed records likely under-represent the true provincial burden. This is a well-recognised limitation of single-centre studies in rural Africa, where cancer registries are incomplete and population-based incidence figures are largely modelled rather than directly measured. The authors’ reliance on secondary records, with 303 of 527 files excluded for incompleteness or non-eligibility, further underscores how fragile routine data systems can be in this setting, and how much investment in health information infrastructure would be needed before true population prevalence can be monitored reliably.

The referral patterns described in the study illuminate the architecture of rural cancer care in the Eastern Cape. Nelson Mandela Academic Hospital functions as the quaternary node for a catchment spanning multiple districts, receiving patients funnelled upward through clinics, community health centres, 45 district hospitals, and regional facilities. Each step in this chain is an opportunity for delay: laboratory turnaround times, availability of urological expertise, and the administrative mechanics of inter-facility referral all influence how quickly a man with an elevated PSA or an abnormal digital rectal examination reaches definitive diagnosis. International evidence on cancer referral systems consistently shows that each additional hand-off is associated with longer time-to-treatment, and the advanced stage distribution in this cohort is exactly what such a fragmented pathway would predict. Strengthening referral pathways, for example by enabling district hospitals to perform PSA testing and by creating clear, time-bound referral criteria for suspected prostate cancer, could compress the diagnostic interval considerably without requiring new tertiary infrastructure.

The global and continental context frames these findings starkly. Prostate cancer accounted for roughly 1.4 million new cases and more than 375,000 deaths worldwide in 2020, and Africa carries an estimated 173,000 incident cases and over 88,000 deaths annually. The ratio of deaths to cases in Africa is far higher than in North America or Europe, a disparity driven less by underlying biology than by stage at diagnosis and access to treatment. African registries themselves acknowledge that these figures are underestimates, since diagnostic capacity and reporting are uneven. Within South Africa, prostate cancer is the most commonly diagnosed malignancy in men, yet national statistics aggregate urban and rural provinces that differ enormously in health system capacity. Studies such as this one, which document stage distribution and referral origin at the district level, help correct that aggregation by showing where the burden concentrates and what kinds of patients the tertiary system actually receives.

The choice of a cross-sectional design using routinely collected records has both strengths and constraints worth appreciating. On the strength side, it provides a snapshot of real-world service delivery rather than the highly selected population that enters clinical trials, and the risk stratification into low, intermediate, and high categories follows standard clinical classification, making results comparable with other hospital-based series. On the constraint side, cross-sectional record review cannot establish causality, cannot measure incidence over time, and cannot capture men who never presented. The chi-square test used to examine geographic associations is appropriate for categorical data but has limited power in a sample of 224 spread across five districts, so the null finding on geography should be interpreted cautiously rather than as definitive evidence of geographic equivalence in risk.

The policy implications extend beyond urology. The Eastern Cape’s combination of high poverty, dispersed rural settlement, and reliance on primary care facilities is shared by many regions across low- and middle-income countries where ageing populations are colliding with cancer systems designed for infectious disease and maternal care. Prostate cancer is particularly amenable to early detection because a cheap blood test and a simple clinical examination can identify candidates for further work-up, and because even in advanced disease, androgen deprivation can extend life for years at relatively low cost. The study’s call for decentralised screening therefore rests on a sound economic as well as clinical logic: shifting the point of first assessment closer to communities, supported by clear referral criteria and community awareness campaigns, is among the most feasible interventions available to a rural health system.

Community-level awareness deserves emphasis because health-seeking behaviour is shaped by knowledge, stigma, and competing priorities. In many South African communities, prostate cancer is poorly recognised, and older men may attribute urinary symptoms to normal ageing or to culturally framed causes, delaying presentation until symptoms become intolerable. Awareness programmes delivered through community health workers, traditional leadership structures, and men’s health campaigns have shown promise in similar settings by normalising discussion of urological symptoms and encouraging older men to accept screening. The finding that late presentation occurs regardless of district suggests such programmes should be deployed broadly rather than targeted only at the most remote areas.

Finally, the study highlights the strategic role of rural teaching hospitals as both care providers and windows into population health. Nelson Mandela Academic Hospital’s patient records, imperfect as they are, constitute one of the few available sources of systematic information about cancer in the OR Tambo region. Investing in the completeness and quality of those records, and in routine analysis of stage and referral origin, would convert routine care into a surveillance asset. Combined with decentralised PSA testing, strengthened district-level diagnostic capacity, and sustained community engagement, the evidence from this cohort points toward a practical pathway for shifting prostate cancer diagnosis in rural South Africa from late and incurable toward earlier and treatable, with measurable benefits for survival and for the efficient use of scarce oncology resources.

Subject of Research: …

Article Title: Socio-demographic characteristics, point prevalence and referral patterns of prostate cancer patients in a South African rural teaching hospital: a cross-sectional study

Article References: Ntlongweni, X., Sibulawa, S., Nomatshila, S. C., Chitha, W. W., Limaphi, A., Sithole, T., & Mabunda, S. A. (2026). Socio-demographic characteristics, point prevalence and referral patterns of prostate cancer patients in a South African rural teaching hospital: a cross-sectional study. Frontiers in Cancer Control and Society, 4, Article 1858841. https://doi.org/10.3389/fcacs.2026.1858841

Image Credits: AI Generated

DOI: 10.3389/fcacs.2026.1858841

Keywords: Socio-demographic, characteristics, point, prevalence, referral, patterns, prostate, cancer, patients, South, African, rural